Literature DB >> 28334711

Quantitative Proteomics Analysis of Ischemia/Reperfusion Injury-Modulated Proteins in Cardiac Microvascular Endothelial Cells and the Protective Role of Tongxinluo.

Qing Li1, He-He Cui2, Yue-Jin Yang1, Xiang-Dong Li1, Gui-Hao Chen1, Xia-Qiu Tian1, Chen Jin1, Qiu-Ting Dong1, Pei-Sen Huang1, Jun Xu1.   

Abstract

BACKGROUND: The protection of endothelial cells (ECs) against reperfusion injury has received little attention. In this study, we used Tandem Mass Tag (TMT) labeling proteomics to investigate the modulated proteins in an in vitro model of cardiac microvascular endothelial cells (CMECs) subjected to ischemia/reperfusion (I/R) injury and their alteration by traditional Chinese medicine Tongxinluo (TXL).
METHODS: Human CMECs were subjected to 2 h of hypoxia followed by 2 h of reoxygenation with different concentrations of TXL Protein expression profiles of CMECs were determined using tandem mass spectrometry. We evaluated several proteins with altered expression in I/R injury and summarized some reported proteins related to I/R injury.
RESULTS: TXL dose-dependently decreased CMEC apoptosis, and the optimal concentration was 800 µg/mL. I/R significantly altered proteins in CMECs, and 30 different proteins were detected between a normal group and a hypoxia and serum deprivation group. In I/R injury, TXL treatment up-regulated 6 types of proteins including acyl-coenzyme A synthetase ACSM2B mitochondrial (ACSM2B), cyclin-dependent kinase inhibitor 1B (CDKN1B), heme oxygenase 1 (HMOX1), transcription factor SOX-17 (SOX17), sequestosome-1 isoform 1 (SQSTM1), and TBC1 domain family member 10B (TBC1D10B). Also, TXL down-regulated 5 proteins including angiopoietin-2 isoform c precursor (ANGPT2), cytochrome c oxidase assembly factor 5 (COA5), connective tissue growth factor precursor (CTGF), cathepsin L1 isoform 2 (CTSL), and eukaryotic elongation factor 2 kinase (LOC101930123). These types of proteins mainly had vital functions, including cell proliferation, stress response, and regulation of metabolic process.
CONCLUSIONS: The study presented differential proteins upon I/R injury through a proteomic analysis. TXL modulated the expression of proteins in CMECs and has a protective role in response to I/R.
© 2017 The Author(s)Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cardiac microvascular endothelial cells; Ischemic/reperfusion injury; Proteomics; Tongxinluo

Mesh:

Substances:

Year:  2017        PMID: 28334711     DOI: 10.1159/000470806

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  5 in total

1.  Atrial remodeling and metabolic dysfunction in idiopathic isolated fibrotic atrial cardiomyopathy.

Authors:  Chang Cui; Xiaohong Jiang; Weizhu Ju; Jiaxian Wang; Daowu Wang; Zheng Sun; Minglong Chen
Journal:  Int J Cardiol       Date:  2018-04-26       Impact factor: 4.164

2.  Traditional Chinese medicine for acute coronary syndrome: A meta-analysis of clinical manifestations and objective indicators.

Authors:  Jiangquan Liao; Tao Li; Yingying Hua; Mingjing Shao; Yan Wang; Zhe Wang; Kangkang Wei; Jiangmeng Chang; Xiaoqiong Zhang; Ming Chen; Xianlun Li; Jinhang Du
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

3.  Lycium barbarum polysaccharides restore adverse structural remodelling and cardiac contractile dysfunction induced by overexpression of microRNA-1.

Authors:  Rong Zhang; Yi Xu; Huifang Niu; Ting Tao; Tao Ban; Linyao Zheng; Jing Ai
Journal:  J Cell Mol Med       Date:  2018-08-17       Impact factor: 5.310

4.  In silico Prediction of miRNA Interactions With Candidate Atherosclerosis Gene mRNAs.

Authors:  Dina Mukushkina; Dana Aisina; Anna Pyrkova; Alma Ryskulova; Siegfried Labeit; Anatoliy Ivashchenko
Journal:  Front Genet       Date:  2020-11-04       Impact factor: 4.599

5.  Genetic-Based Hypertension Subtype Identification Using Informative SNPs.

Authors:  Yuanjing Ma; Hongmei Jiang; Sanjiv J Shah; Donna Arnett; Marguerite R Irvin; Yuan Luo
Journal:  Genes (Basel)       Date:  2020-10-27       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.